{"DataElement":{"publicId":"5505323","version":"1","preferredName":"BCR/ABL1 Fusion Gene Detection Level Type","preferredDefinition":"A description of the BCR/ABL1 fusion gene detection level.","longName":"5560119v1.0:5505266v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5560119","version":"1","preferredName":"BCR/ABL1 Fusion Gene Detection","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia._The activity of perceiving, discerning, discovering or identifying.","longName":"4534804v1.0:2528336v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4534804","version":"1","preferredName":"BCR/ABL1 Fusion Gene","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","longName":"C94600","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0552E3BE-9971-866A-E050-BB89AD437D7E","latestVersionIndicator":"Yes","beginDate":"2014-10-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-10-13","modifiedBy":"ONEDATA","dateModified":"2014-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2528336","version":"1","preferredName":"Detection","preferredDefinition":"No value exists.","longName":"C16210","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"20167BA5-60AA-19C4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-10-18","modifiedBy":"ONEDATA","dateModified":"2006-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"403F7A7B-E37A-4707-E053-F662850A10E6","latestVersionIndicator":"Yes","beginDate":"2016-11-01","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-01","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5505266","version":"1","preferredName":"BCR/ABL1 Fusion Gene Detection Level Type","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia._The activity of perceiving, discerning, discovering or identifying._A position on a scale measuring intensity, quality, or amount._Something distinguishable as an identifiable class based on common qualities.","longName":"5505266v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"<= 0.1 %","valueDescription":"Less Than or Equal To 0.1 Percent Unit","ValueMeaning":{"publicId":"5582747","version":"1","preferredName":"Less Than or Equal To 0.1 Percent Unit","longName":"5582747","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A number with no fractional part, including the negative and positive numbers as well as zero.::0.1: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than or Equal To","conceptCode":"C61586","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4284CEBA-AFC2-5AE7-E053-F662850A1F7C","latestVersionIndicator":"Yes","beginDate":"2016-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4284CEBA-AFDB-5AE7-E053-F662850A1F7C","beginDate":"2016-10-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-30","modifiedBy":"ONEDATA","dateModified":"2016-11-30","deletedIndicator":"No"},{"value":"> 0.1 %","valueDescription":"Greater Than 0.1 Percent Unit","ValueMeaning":{"publicId":"5582748","version":"1","preferredName":"Greater Than 0.1 Percent Unit","longName":"5582748","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::0.1: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4284CEBA-AFE9-5AE7-E053-F662850A1F7C","latestVersionIndicator":"Yes","beginDate":"2016-11-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4284CEBA-B002-5AE7-E053-F662850A1F7C","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-30","modifiedBy":"ONEDATA","dateModified":"2016-11-30","deletedIndicator":"No"},{"value":"< 3-log reduction from standardized baseline","valueDescription":"Less Than 3-Log Reduction in Ph+ Cells Standard Baseline","ValueMeaning":{"publicId":"5602178","version":"1","preferredName":"Less Than 3-Log Reduction in Ph+ Cells Standard Baseline","longName":"5602178","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A 1000 times reduction in the Philadelphia Chromosome positive cells.: A document, established by consensus and approved by a recognized body, that provides, for common and repeated use, rules, guidelines or characteristics for activities or their results.: A starting point to which things may be compared.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"3-Log Reduction in Ph+ Cells","conceptCode":"C131092","definition":"A 1000 times reduction in the Philadelphia Chromosome positive cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Standard","conceptCode":"C81893","definition":"A document, established by consensus and approved by a recognized body, that provides, for common and repeated use, rules, guidelines or characteristics for activities or their results.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"438C9323-C95E-2193-E053-F662850A2171","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"438C9323-C977-2193-E053-F662850A2171","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-13","modifiedBy":"ONEDATA","dateModified":"2016-12-13","deletedIndicator":"No"},{"value":">= 3-log reduction from standardized baseline","valueDescription":"Greater Than or Equal To 3-Log Reduction in Ph+ Cells Standard Baseline","ValueMeaning":{"publicId":"5602179","version":"1","preferredName":"Greater Than or Equal To 3-Log Reduction in Ph+ Cells Standard Baseline","longName":"5602179","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.: A 1000 times reduction in the Philadelphia Chromosome positive cells.: A document, established by consensus and approved by a recognized body, that provides, for common and repeated use, rules, guidelines or characteristics for activities or their results.: A starting point to which things may be compared.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"3-Log Reduction in Ph+ Cells","conceptCode":"C131092","definition":"A 1000 times reduction in the Philadelphia Chromosome positive cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Standard","conceptCode":"C81893","definition":"A document, established by consensus and approved by a recognized body, that provides, for common and repeated use, rules, guidelines or characteristics for activities or their results.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"438C9323-C986-2193-E053-F662850A2171","latestVersionIndicator":"Yes","beginDate":"2016-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"438C9323-C99F-2193-E053-F662850A2171","beginDate":"2016-10-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-12-13","modifiedBy":"ONEDATA","dateModified":"2016-12-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5581592","version":"1","preferredName":"BCR/ABL1 Fusion Gene Detection Level Type","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.:The activity of perceiving, discerning, discovering or identifying.:A position on a scale measuring intensity, quality, or amount.:Something distinguishable as an identifiable class based on common qualities.","longName":"C94600:C16210:C25554:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Level","conceptCode":"C25554","definition":"A position on a scale measuring intensity, quality, or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"427203EB-1C5B-5ABC-E053-F662850A81BA","latestVersionIndicator":"Yes","beginDate":"2016-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-29","modifiedBy":"ONEDATA","dateModified":"2016-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E2049DE-51C5-6B60-E053-F662850AE626","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-05","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMLP_LSLE_BCR_ABL_detect_level","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LTHM_BCR_ABL_detect_level","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_DABR_BCR_ABL_detect_level","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_PHPI_BCR_ABL_detect_level","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify level of detection","type":"Application Standard Question Text","description":"Specify level of detection","url":null,"context":"NHLBI"},{"name":"What was the BCR/ABL1 fusion","type":"Preferred Question Text","description":"What was the BCR/ABL1 fusion gene detection level?","url":null,"context":"NHLBI"},{"name":"Specify level of detection","type":"Alternate Question Text","description":"Specify level of detection","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E209D74-7328-0BC2-E053-F662850AF052","latestVersionIndicator":"Yes","beginDate":"2016-10-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-05","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}